EXACT SCIENCES (EXK MU) stock market data APIs
€88.8572
0(0%)
as of March 23, 2026
Try our APIs with
free plan!
EXACT SCIENCES Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for EXK.MU.
Prev. Close
88.8572
Open
88.8572
High
88.8572
Low
88.8572
52 wk Range
33.805-91.4
Market Cap
12 100 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EXACT SCIENCES data using free add-ons & libraries
Get EXACT SCIENCES Fundamental Data
EXACT SCIENCES Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EXACT SCIENCES News
New
Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences
Abbott Laboratories (NYSE:ABT) is one of the Best Conservative Stocks to Buy Right Now.On March 23, the company announced that it had completed the acquisition of Exact Sciences. As a result of this, ...
Abbott completes acquisition of Exact Sciences
Establishes Abbott as a leader in fast-growing cancer screening and diagnostics segments Advances Abbott's mission to make healthcare more accessible and give people more control over their health AB...
How Walgreens’ Pharmacy-Led Cologuard Expansion At Exact Sciences (EXAS) Has Changed Its Investment Story
On 13 March 2026, Walgreens announced a nationwide initiative with Exact Sciences and Workflow Services to expand access to Cologuard, an FDA-approved, non-invasive colorectal cancer screening test fo...
Abbott acquisition of Exact Sciences set to close on March 23, 2026
Announcement follows receipt of all regulatory clearances necessary for closing Transaction enables Abbott to enter and lead in fast-growing cancer screening and diagnostics segments, serving millions...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
